Neurotech International Limited Stock
Equities
NTI
AU000000NTI9
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.074 AUD | -1.33% | -18.68% | +7.25% |
Apr. 17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
Apr. 17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
Sales 2022 | 608K 400K | Sales 2023 | 1.19M 786K | Capitalization | 34.96M 23M |
---|---|---|---|---|---|
Net income 2022 | -3M -1.97M | Net income 2023 | -7M -4.6M | EV / Sales 2022 | 77.3 x |
Net cash position 2022 | 1.9M 1.25M | Net cash position 2023 | 5.03M 3.31M | EV / Sales 2023 | 25.1 x |
P/E ratio 2022 |
-14.5
x | P/E ratio 2023 |
-4.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 78.29% |
1 day | -1.33% | ||
1 week | -18.68% | ||
Current month | -17.78% | ||
1 month | -25.25% | ||
3 months | -22.11% | ||
6 months | +27.59% | ||
Current year | +7.25% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Operating Officer | - | 22-03-07 | |
Erlyn Dawson
SEC | Corporate Secretary | - | 19-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Davies
CHM | Chairman | - | 19-04-15 |
Thomas Duthy
BRD | Director/Board Member | - | 22-08-31 |
Gerald Quigley
BRD | Director/Board Member | - | 22-07-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.074 | -1.33% | 918 156 |
24-05-07 | 0.075 | -8.54% | 9,569,524 |
24-05-06 | 0.082 | -9.89% | 12,065,940 |
24-05-02 | 0.091 | 0.00% | 598,446 |
24-05-01 | 0.091 | +1.11% | 1,018,382 |
Delayed Quote Australian S.E., May 08, 2024 at 12:52 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+7.25% | 50.46M | |
-0.77% | 3.3B | |
-8.37% | 165M | |
-13.33% | 85.38M | |
-47.19% | 50.65M |
- Stock Market
- Equities
- NTI Stock